Macrophages in the Mammary Gland Stem Cell Niche: A Double‐Edged Sword in Tissue Regeneration and Tumor Initiation
BioEssays · 2026
DOI: 10.1002/bies.70108 ↗At a glance
Übersichtsarbeit in BioEssays, 2026. Written by Eunmi Lee and 1 co-authors. Institution: Department of Molecular Biology, Princeton University, Princeton, New Jersey, USA. Major MEDLINE topics: Macrophages, Stem Cell Niche, Neoplastic Stem Cells, Mammary Glands, Human. 97 references. Funded by: New Jersey Commission on Cancer Research, Ludwig Cancer Research, the Brewster Foundation, the Breast Cancer Research Foundation, Susan G. Komen Foundation.
Abstract (original language)
Stem cell populations employ cell‐intrinsic and niche‐mediated mechanisms to preserve long‐term self‐renewal and regenerative potential. We propose that tumor‐initiating cells (TICs) hijack this developmental circuitry to sustain their growth and establish an early immunosuppressive microenvironment during malignant progression. Recent work implicates CXCR4 + tissue‐resident macrophages (TRMs) in the mammary gland as a central orchestrator of this process. Conserved CXCL12/CXCR4‐AKT‐β‐catenin signaling links CXCR4 + TRM support of normal mammary stem cells to TIC maintenance, underscoring how developmental niches are exploited in malignancy. During tumorigenesis, aberrant CXCL12 production from tumor‐associated fibroblasts promotes the expansion of CXCR4 + TRMs, while CXCR4 signaling enhances ALDH1A2‐dependent retinoic acid production, which induces regulatory T cells and thereby suppresses anti‐tumor immunity at the earliest stages of tumor development. From this perspective, early immune evasion is not only a hallmark of cancer but also a therapeutic window. Targeting TRMs early in cancer development could delay, or even prevent, malignant initiation. More broadly, we propose that TIC–niche crosstalk constitutes a tractable vulnerability, and that incorporating TRM‐directed interventions alongside conventional and immune‐based therapies may shift the balance toward durable tumor control.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Molecular Biology, Princeton University, Princeton, New Jersey, USA.
- Ludwig Institute for Cancer Research Princeton Branch, Princeton, New Jersey, USA.
- Cancer Metabolism and Growth Program, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
Funding
- New Jersey Commission on Cancer Research
- Ludwig Cancer Research, the Brewster Foundation, the Breast Cancer Research Foundation
- Susan G. Komen Foundation
- American Cancer Society
Cite
APA
Lee, E., & Kang, Y. (2026). Macrophages in the Mammary Gland Stem Cell Niche: A Double‐Edged Sword in Tissue Regeneration and Tumor Initiation. BioEssays. https://doi.org/10.1002/bies.70108
Vancouver
Lee E, Kang Y. Macrophages in the Mammary Gland Stem Cell Niche: A Double‐Edged Sword in Tissue Regeneration and Tumor Initiation. BioEssays. 2026. doi:10.1002/bies.70108
BibTeX
@article{Lee2026,
author = {Lee, Eunmi and Kang, Yibin},
title = {Macrophages in the Mammary Gland Stem Cell Niche: A Double‐Edged Sword in Tissue Regeneration and Tumor Initiation},
journal = {BioEssays},
year = {2026},
doi = {10.1002/bies.70108}
}
EUVIMED